Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use Is Associated With Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis-Reference-Cited by-同舟云学术

Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use Is Associated With Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis

Published:2021-10-19 Issue:12 Volume:116 Page:2446-2454
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Ramsey Mitchell L.,Gokun Yevgeniya,Sobotka Lindsay A.,Wellner Michael R.,Porter Kyle,Kirkby Stephen E.,Li Susan S.,Papachristou Georgios I.,Krishna Somashekar G.,Stanich Peter P.,Hart Phil A.,Conwell Darwin L.,Lara Luis F.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference37 articles.

1. CFTR: A new horizon in the pathomechanism and treatment of pancreatitis;Hegyi;Rev Physiol Biochem Pharmacol,2016

2. Cystic fibrosis of the pancreas: The role of CFTR channel in the regulation of intracellular Ca(2+) signaling and mitochondrial function in the exocrine pancreas;Madácsy;Front Physiol,2018

3. The physiology and pathophysiology of pancreatic ductal secretion: The background for clinicians;Pallagi;Pancreas,2015

4. Recurrent acute pancreatitis in patients with cystic fibrosis with normal pancreatic enzymes;Shwachman;Pediatrics,1975

5. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis;Ooi;J Cyst Fibros,2012

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline multigene panel testing in acute and chronic pancreatitis;PLOS ONE;2024-08-22

2. ECFS standards of care on CFTR-related disorders: Identification and care of the disorders;Journal of Cystic Fibrosis;2024-07

3. Update on advances in cystic fibrosis towards a cure and implications for primary care clinicians;Current Problems in Pediatric and Adolescent Health Care;2024-06

4. Pancreatitis in cystic fibrosis: Presentation, medical and surgical management, and the impact of modulator therapies;Pediatric Pulmonology;2024-03-19

5. Preventive service utilization among adults with cystic fibrosis covered by private insurance is comparable to the general population;Journal of Cystic Fibrosis;2024-03